Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Finns consider extending breast screening age:

This article was originally published in Clinica

Executive Summary

A number of Finnish municipalities will need "notable extra resources" to extend the upper age limit of its breast cancer screening programme from 59 to 69 years, as recently recommended by the health technology assessment agency, FinOHTA. Nationally, there are sufficient screening devices and experienced professionals, but their geographical distribution is uneven, says FinOHTA. "It is likely that the ministry will give guidance on extending screening to older age groups, but has not made a firm decision yet," Marjukka Makela, research professor at FinOHTA, told Clinica. FinOHTA estimated the cost per life-year saved by mammography screening to be FMk36,600 ($5,500). When all factors were varied within reasonable limits, the estimate ranged from FMk11,600 to FMk223,000.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT070733

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel